Bionews-tx.com Website Review

uh-invented, less invasive surgical option for breast cancer now available in us. cprit awards $8.2m to utmb for 3 cancer research and prevention projects. md anderson researchers suggest repeat biopsies during treatment may reveal response, resistance to cancer therapy. uh developing cutting-edge strategies to regenerate heart muscle cell formation. moleculin, working with md anderson, presents new data on glucose decoy, potential therapy for malignant gliomas. ut southwestern researchers identify potential new target for small cell lung cancer therapies. md anderson dna study reveals new insights in colon cancer, may help personalize treatment options. federal 340b drug discount program - the gathering storm june 16th, 2015. successful marketing strategies for biotech, life sciences companies must be data-driven, customer-centric march 25th, 2014. primary progressive multiple sclerosis: what you need to know january 24th, 2014. on zika virus, dr. peter hotez thinks “haiti is going to get decimated;” worried about “some of the historic wards of. on feb. 1, the world health organization (who) convened the first meeting of the international health regulations emergency committee on zika virus, in which they as*essed the severity of the global health risks that are as*ociated with the “explosive spread” of the zika. uta researcher developing innovative nanotechnology to monitor blood glucose levels. md anderson study points to involvement of epidermal growth factor receptor in colorectal cancer recurrence. uta researchers develop technology to create ‘smart’ wound bandage tool. moleculin, working with md anderson, presents new data on glucose decoy, potential therapy for malignant gliomas. moleculin biotech recently presented new data on its glucose decoy 2-dg, known as wp1122, during a scientific session at the 28th annual international carbohydrate symposium in new orleans. some of moleculin’s anti-cancer drug candidates are developed based on